Press release
Secondary Progressive Multiple Sclerosis Clinical Trials | A Drug Pipeline Analysis Report 2024
Secondary Progressive Multiple Sclerosis Pipeline Analysis Report 2024
Download a sample report @ https://www.delveinsight.com/report-store/secondary-progressive-multiple-sclerosis-spms-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Key Takeaways from the Secondary Progressive Multiple Sclerosis Pipeline Report
Over 5+ Secondary Progressive Multiple Sclerosis pipeline therapies are in various stages of development, and their anticipated acceptance in the Secondary Progressive Multiple Sclerosis market would significantly increase market revenue.
Leading Secondary Progressive Multiple Sclerosis companies developing novel drug candidates to improve the Secondary Progressive Multiple Sclerosis treatment landscape include Sanofi, Medicinova, Immune Response Biopharma, AB Science, and others.
Promising Secondary Progressive Multiple Sclerosis pipeline therapies in various stages of development include Tolebrutinib, Ibudilast, NeuroVax, Masitinib, and others.
Secondary Progressive Multiple Sclerosis Overview
Secondary Progressive Multiple Sclerosis (SPMS) is a form of Multiple Sclerosis (MS) that follows an initial period of relapsing-remitting MS (RRMS). In SPMS, the disease progresses steadily over time, with or without occasional relapses and remissions. This progressive worsening of symptoms is due to the ongoing damage to the myelin sheath that insulates nerve fibers and the nerve fibers themselves in the central nervous system (CNS).
Key Features of Secondary Progressive Multiple Sclerosis:
1. Progression of Disability: SPMS is characterized by a gradual and steady worsening of neurological symptoms and disability. This progression can affect various functions, including mobility, cognitive abilities, vision, and bladder control.
2. Variable Onset: The transition from RRMS to SPMS can occur at different times for different individuals. Some people may experience a more rapid progression, while others may have a slower decline.
3. Relapses and Remissions: While the disease primarily progresses, some individuals with SPMS may still experience relapses (exacerbations) and remissions (periods of stability or slight improvement). However, these are less common and less pronounced than in the relapsing-remitting phase.
4. Pathology: The underlying pathology involves continued inflammation, demyelination, and neurodegeneration in the CNS. This leads to the accumulation of disability over time.
5. Diagnosis: Diagnosing SPMS can be challenging and typically involves a combination of clinical evaluation, MRI imaging, and a review of the patient's history of MS symptoms and disease course.
6. Treatment: There is no cure for SPMS, but treatment focuses on managing symptoms, slowing disease progression, and improving quality of life. Treatment options may include disease-modifying therapies, symptomatic treatments, and rehabilitation services.
7. Prognosis: The prognosis for individuals with SPMS varies widely. Some may experience a relatively slow progression of disability, while others may have a more rapid decline. Factors influencing the prognosis include the severity of the initial RRMS, the duration of the relapsing-remitting phase, and the effectiveness of treatment.
Management and Treatment:
- Disease-Modifying Therapies (DMTs): While not all DMTs are approved specifically for SPMS, some may help slow disease progression and reduce the frequency of relapses.
- Symptomatic Treatments: These address specific symptoms such as spasticity, pain, fatigue, and cognitive impairment. Examples include muscle relaxants, pain medications, and cognitive rehabilitation.
- Rehabilitation: Physical therapy, occupational therapy, and speech therapy can help manage disability and improve functional abilities.
- Lifestyle Modifications: Exercise, a healthy diet, and stress management techniques can also play a role in managing symptoms and improving overall well-being.
Secondary Progressive Multiple Sclerosis is a complex and challenging condition that requires a comprehensive and individualized approach to management. Ongoing research continues to explore new treatments and interventions to improve outcomes for individuals with SPMS.
To know more about in detail, visit: https://www.delveinsight.com/report-store/secondary-progressive-multiple-sclerosis-spms-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Secondary Progressive Multiple Sclerosis Pipeline Analysis: Drug Profile
NeuroVax (Immune Response BioPharma) is a therapeutic TCR (T-cell receptor) peptide vaccine for SPMS. In March 2020, the company initiated a Phase II/III in patients with SPMS, currently the study is in recruiting phase. The study is estimated to complete by 2024, with an estimated enrollment of 200 participants. However, company has not provided any updates on the drug. In March 2014, NeuroVax was granted Fast Track Designation by FDA for SPMS.
Discover more about the emerging Secondary Progressive Multiple Sclerosis drugs @ https://www.delveinsight.com/sample-request/secondary-progressive-multiple-sclerosis-spms-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Secondary Progressive Multiple Sclerosis Key Companies
Sanofi
Medicinova
Immune Response Biopharma
AB Science
Secondary Progressive Multiple Sclerosis Pipeline Therapies
Tolebrutinib
Ibudilast
NeuroVax
Masitinib
Secondary Progressive Multiple Sclerosis Pipeline Therapeutics Assessment
By development stage
By product type
By route of administration
By molecule type
By MOA type
Scope of the Secondary Progressive Multiple Sclerosis Pipeline Report
Coverage: Global
Key Secondary Progressive Multiple Sclerosis Companies: Sanofi, Medicinova, Immune Response Biopharma, AB Science, and others
Key Secondary Progressive Multiple Sclerosis Pipeline Therapies: Tolebrutinib, Ibudilast, NeuroVax, Masitinib, and others
Find out more about the Secondary Progressive Multiple Sclerosis treatment options in development @ https://www.delveinsight.com/sample-request/secondary-progressive-multiple-sclerosis-spms-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Table of Contents
1. Introduction
2. Executive Summary
3. Overview
4. Pipeline Therapeutics
5. Late-Stage Products (Phase III)
6. Mid-Stage Products (Phase II)
7. Early Stage Products (Phase I/II)
8. Preclinical Stage Products
9. Discovery Stage Products
10. Therapeutic Assessment
11. Inactive Products
12. Collaborations Assessment- Licensing / Partnering / Funding
13. Unmet Needs
14. Market Drivers and Barriers
15. Appendix
16. About DelveInsight
Trending Reports By DelveInsight:
Functional Constipation Market
https://www.delveinsight.com/report-store/chronic-constipation-market
Lebers Hereditary Optic Neuropathy Lhon Market https://www.delveinsight.com/report-store/lebers-hereditary-optic-neuropathy-lhon-market
Gastric Neuroendocrine Tumors Market
https://www.delveinsight.com/report-store/gastric-neuroendocrine-tumors-market
Immune Thrombocytopenic Purpura Market
https://www.delveinsight.com/report-store/immune-thrombocytopenia-itp-market
Visceral Pain Associated With GI Disorders Market
https://www.delveinsight.com/report-store/visceral-pain-associated-with-gi-disorders-market
Bullous Pemphigoid Market
https://www.delveinsight.com/report-store/bullous-pemphigoid-market
Cyclin-dependent Kinase-like 5 Deficiency Disorder Market https://www.delveinsight.com/infographics/cyclin-dependent-kinase-like-5-cdkl5-deficiency-disorder-market
Myocarditis Market
https://www.delveinsight.com/report-store/myocarditis-market
Recurrent Blood Clots Market
https://www.delveinsight.com/report-store/recurrent-blood-clots-thrombophilia-market
Zollinger-ellison Syndrome Market
https://www.delveinsight.com/report-store/zollinger-ellison-syndrome-market
Age-related Hearing Loss Medical Device Market
https://www.delveinsight.com/blog/age-related-hearing-loss-device-market
Heart Sounds Sensors Market
https://www.delveinsight.com/report-store/heart-sounds-sensors-electronic-stethoscope-market
Hypoplastic Left Heart Syndrome Hlhs Market
https://www.delveinsight.com/report-store/hypoplastic-left-heart-syndrome-market
Infectious Arthritis/Septic Arthritis Market
https://www.delveinsight.com/report-store/infectious-arthritisseptic-arthritis-market
Plasmacytoma Market
https://www.delveinsight.com/report-store/plasmacytoma-market
Agoraphobia Market
https://www.delveinsight.com/report-store/agoraphobia-market
Clinically Isolated Syndrome CIS Market
https://www.delveinsight.com/report-store/clinically-isolated-syndrome-cis-market
Fucosidosis Market
https://www.delveinsight.com/report-store/fucosidosis-market
Major Depressive Disorder Market
https://www.delveinsight.com/report-store/major-depressive-disorder-market
Neuronal Ceroid-lipofuscinoses Market
https://www.delveinsight.com/report-store/neuronal-ceroid-lipofuscinoses-cln1-disease-market
Orthotic Devices Market
https://www.delveinsight.com/report-store/orthotic-devices-market
Contact Us
Kritika Rehani
info@delveinsight.com
+14699457679
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Secondary Progressive Multiple Sclerosis Clinical Trials | A Drug Pipeline Analysis Report 2024 here
News-ID: 3768571 • Views: …
More Releases from DelveInsight Business Research LLP
Personal Care Contract Manufacturing Market Forecast Report 2032: Competitive La …
DelveInsight's Personal Care Contract Manufacturing Market Insights Report 2032 provides the current and forecast market analysis, individual leading Personal Care Contract Manufacturing Companies market shares, challenges, Personal Care Contract Manufacturing Market Drivers, barriers, trends, and key market Personal Care Contract Manufacturing companies in the market.
To read more about the latest highlights related to the Personal Care Contract Manufacturing Market, get a snapshot of the key highlights entailed in the Market…
Burn Market Size Report 2032: Revenue Growth, Market Share, Companies and Opport …
DelveInsight's Burn Market Insights Report 2032 provides the current and forecast market analysis, individual leading Burn Companies market shares, challenges, Burn Market Drivers, barriers, trends, and key market Burn companies in the market.
To read more about the latest highlights related to the Burn Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/burn-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Burn Market Report
• The Burn market was valued at…
Global Automatic Mechanical Cardiopulmonary Resuscitation Devices Market Outlook …
DelveInsight's Automatic Mechanical Cardiopulmonary Resuscitation Devices Market Insights Report 2032 provides the current and forecast market analysis, individual leading Automatic Mechanical Cardiopulmonary Resuscitation Devices Companies market shares, challenges, Automatic Mechanical Cardiopulmonary Resuscitation Devices Market Drivers, barriers, trends, and key market Automatic Mechanical Cardiopulmonary Resuscitation Devices companies in the market.
To read more about the latest highlights related to the Automatic Mechanical Cardiopulmonary Resuscitation Devices Market, get a snapshot of the key…
Gastrointestinal Anastomosis Market Size Report 2032: Emerging Technologies, App …
DelveInsight's Gastrointestinal Anastomosis Market Insights Report 2032 provides the current and forecast market analysis, individual leading Gastrointestinal Anastomosis Companies market shares, challenges, Gastrointestinal Anastomosis Market Drivers, barriers, trends, and key market Gastrointestinal Anastomosis companies in the market.
To read more about the latest highlights related to the Gastrointestinal Anastomosis Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/gastrointestinal-anastomosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Gastrointestinal Anastomosis Market…
More Releases for Multiple
Mango AI's Multiple Face Swap Video Tool Changes Multiple Faces Instantly
In today's digital world, creating eye-catching and unique content is essential for standing out. The ability to swap multiple faces in a single video opens up creative possibilities, whether for personalized content, comedy or parody videos, or engaging social media posts. Mango AI, developed by Mango Animate, is excited to announce the launch of its advanced multiple face swap video (https://mangoanimate.com/ai/multiple-face-swap-video) tool, which is designed to simplify the creation of…
Multiple Sclerosis Drugs Market
Global Multiple Sclerosis Drugs Market Size research report offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market.
Get a Sample Copy of the Report at - https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/100386
Multiple Sclerosis (MS) is an immune-mediated disease affecting the central nervous system. It is characterized by demyelination, inflammation, degenerative changes such as progressive brain and spinal cord atrophy and neuroaxonal…
Massive Multiple Input Multiple Output (MIMO) Market May Set New Growth Story
A Latest intelligence report published by MR Forecast with title "Global Massive Multiple Input Multiple Output (MIMO) Market Outlook to 2032. A detailed study accumulated to offer Latest insights about acute features of the Massive Multiple Input Multiple Output (MIMO) market. This report provides a detailed overview of key factors in the Global Massive Multiple Input Multiple Output (MIMO) Market and factors such as driver, restraint, past and current trends,…
Multiple Sclerosis Drugs Market - Progressing Towards a Cure: Advancing Multiple …
Newark, New Castle, USA: The "Multiple Sclerosis Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Multiple Sclerosis Drugs Market: https://www.growthplusreports.com/report/multiple-sclerosis-drugs-market/7983
This latest report researches the industry structure,…
Multiple Sclerosis Drugs Market - Empowering Resilience, Embracing Possibilities …
Newark, New Castle, USA - new report, titled Multiple Sclerosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Multiple Sclerosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Multiple Sclerosis Drugs market. The report offers an overview of…
Massive MIMO (Multiple-input multiple-output) Market 2022-2028 | Detailed Report
The market report delivers an all-inclusive analysis of the market structure along with a forecast of the various segments and sub-segments of the Massive MIMO (Multiple-input multiple-output) industry. This wide-ranging market research report acts as a backbone for the success of business in any niche. The Massive MIMO (Multiple-input multiple-output) market survey report has been prepared by conducting market research in a systematic manner. Moreover, the Massive MIMO (Multiple-input multiple-output)…
